News

|

Feeds

|

Email

DUBLIN, Aug. 4, 2023 /PRNewswire/ -- The "Cell Therapy Clinical Activity and Process Automation" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cell therapy, a revolutionary approach to treating malignancies, has opened new doors for patients previously limited to palliative care. Particularly, chimeric antigen receptor (CAR) modified T cell therapies have shown remarkable effectiveness in combating hematological malignancies.

These therapies involve the modification of patient-derived (autologous) or donor-derived (allogeneic) T cells to express a CAR, a chimeric construct that includes a signaling domain from the T cell receptor and a single chain variable fragment (scFv).

The process of producing autologous CAR T cells involves several common steps, including isolation and activation of the patient's white blood cells (WBCs), transduction with the CAR transgene, expansion to achieve the required cell numbers, and final formulation.

After rigorous quality control testing and preparatory lymphodepleting chemotherapy, the modified T cell product is administered to the patient, offering new hope in the fight against malignancies.

Key Topics Covered:

1. Executive Summary

    --  Market Segments
    --  Competing Technologies
    --  Bioreactors
    --  Microcarriers
    --  Demographics and Growth
    --  Market Drivers
    --  Risk Factors

2. Cell Culture Monitoring

    --  Probe Based Sensors
    --  Capsule Technology
    --  Disposable Sensor Patches
    --  Quality Control
    --  Technical Challenges
    --  Electronic Interference

3. Enabling Technology

    --  Autonomous Sensor Technology
    --  Wireless Data Transmission
    --  Analyte Concentration
    --  Technical Limitations

4. Automated Cell Therapy Manufacturing Platforms

    --  Next Generation Platforms
    --  Cell Therapy Process Convergence
    --  CT Process Standardization
    --  Robotics
    --  Market Factors
    --  Regulations
    --  FDA
    --  GMP

5. Company Profiles

    --  Lonza
    --  Agilent
    --  Fujifilm
    --  Gamma Biosciences
    --  Codiak Biosciences
    --  Mitenyi Biotec
    --  Cesca Therapeutics
    --  Thermo Fisher Scientific
    --  Gibco
    --  UCSF
    --  FresenusKabi
    --  Cellares
    --  Amgen
    --  AstraZeneca
    --  Bristol Myers Squibb
    --  Eli Lilly
    --  EDM Serono
    --  Genentech
    --  Pfizer
    --  Astellas
    --  Celltrion
    --  Daiichi Sankyo
    --  Genentech
    --  GlaxoSmithKline
    --  Imclone
    --  Janssen Biotech
    --  Kyowa Kirin
    --  Merck Sharp Dohme
    --  Mylan GmbH
    --  Regeneron Pharmaceuticals
    --  Samsung Bioepis Co Ltd
    --  Spectrum Pharms
    --  United Therapeutics
    --  Wyeth Pharms
    --  CliniMACS
    --  Cytiva
    --  Zellwerk GmbH
    --  Wilson Wolf
    --  Celgene
    --  Juno Therapeutics
    --  Novartis Pharma GmbH
    --  Fraunhofer Institut
    --  Kite Pharma
    --  CRISPR

For more information about this report visit https://www.researchandmarkets.com/r/2sjgk9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/cell-therapy-clinical-activity-and-process-automation-research-report-2023---examine-cell-therapys-shift-from-palliative-to-curative-care-301893519.html

SOURCE Research and Markets

Email

|

Slashdot

|

Digg

|

Del.icio.us

|

Feeds

RELATED NEWS ARTICLES

Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026 Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026 DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026 Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026 Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026 Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026 Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026 Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026 The Roadmap to Securing Your Own Digital Domain is Now Available | Jan 22, 2026 Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026